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Background: Accumulating evidence reveals that intrauterine growth retardation (IUGR) can cause varying degrees
of pulmonary arterial hypertension (PAH) later in life. Moreover, epigenetics plays an important role in the fetal
origin of adult disease. The goal of this study was to investigate the role of epigenetics in the development of PAH
following IUGR.
Methods: The IUGR rats were established by maternal undernutrition during pregnancy. Pulmonary vascular
endothelial cells (PVEC) were isolated from the rat lungs by magnetic-activated cell sorting (MACS). We investigated
epigenetic regulation of the endothelin-1 (ET-1) gene in PVEC of 1-day and 6-week IUGR rats, and response of IUGR
rats to hypoxia.
Results: The maternal nutrient restriction increased the histone acetylation and hypoxia inducible factor-1α (HIF-1α)
binding levels in the ET-1 gene promoter of PVEC in IUGR newborn rats, and continued up to 6 weeks after birth.
These epigenetic changes could result in an IUGR rat being highly sensitive to hypoxia later in life, causing more
significant PAH or pulmonary vascular remodeling.
Conclusions: These findings suggest that epigenetics is closely associated with the development of hypoxic PAH
following IUGR, further providing a new insight for improved prevention and treatment of IUGR-related PAH.
Keywords: Epigenetics, Pulmonary arterial hypertension, Endothelial cells, Endothelin-1, Intrauterine growth
retardationIntroduction
An adverse intrauterine environment, such as uteropla-
cental vascular insufficiency and maternal malnutrition,
may impact the development of the fetus resulting in fetal
growth restriction or intrauterine growth retardation
(IUGR) [1,2]. Their perinatal mortality is four to ten times
higher than that of normally grown babies [1,3]. Moreover,
a large number of epidemiological studies reveal that
IUGR or low birth weight has been linked to the later
development of diseases in adulthood, including type 2
diabetes and hypertension [4-6].
Compared with large for gestational age (LGA) infants,
IUGR or small for gestational age (SGA) infants show a* Correspondence: dulizhong@yahoo.com.cn
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reproduction in any medium, provided the orsignificantly greater risk of developing chronic lung
disease (CLD) [7]. Premature infants with extremely low
birth weight who presented initially with no lung disease
or only a mild form of respiratory distress syndrome
visible on chest radiograms may have an acute pulmonary
hypertension episode and right ventricular dysfunction [8].
Moreover, a transient perinatal insult to the pulmonary
circulation could have a persistent effects that, when
activated later in life, predisposes to developing sig-
nificant pulmonary vasoconstriction. These survivors
would be at a greater risk of developing pulmonary
arterial hypertension (PAH) later in life [9]. Another
study demonstrated that hypoxia-induced IUGR rats had
important deleterious consequences on the cardiopulmon-
ary function of the offspring later in life, resulting in left
ventricular diastolic dysfunction and PAH [10]. Accumulat-
ing evidence revealed that IUGR induced by intrauterineThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 The sampling age of different experimental group
rats. Up arrow represents sampling time, solid triangle represents
the time of intervention, d1 represents 1 day after birth.
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pulmonary vascular remodeling.
There is evidence that epigenetics play an important
role in the fetal origin of adult disease [11-14]. Epigenetics
refers to all heritable changes in phenotype or in gene ex-
pression states that are not involved in the DNA sequence
itself, including histone modification and DNA methylation
[15]. To date, epigenetic regulations in adult onset diseases
following IUGR, including type 2 diabetes and hyperten-
sion, have been extensively investigated [5,15-17]. Rexhaj
et al. found that in mice maternal undernutrition would
induce pulmonary vascular dysfunction in the offspring by
a DNA methylation of lung tissue [18]. However, data
about whether epigenetic regulation is involved in the
pathogenesis of PAH following intrauterine environmental
changes is limited.
In a previous study, we found that the epigenetic modifi-
cation of the endothelial nitric oxide synthase (eNOS)
gene in persistent pulmonary hypertension of the newborn
(PPHN) rats induced eNOS protein expression [19]. How-
ever, the increased eNOS expression did not completely
offset the effect of vasoconstrictors, such as endothelin-1
(ET-1), and subsequent development of PPHN [19,20]. A
number of clinical studies demonstrated that increased
ET-1 was strongly associated with PAH [21-23]. Similar
to the eNOS gene, the ET-1 gene expression was also
regulated by epigenetics [24-26]. Some transcription
factor binding sites, including hypoxia-inducible factor-
1α (HIF-1α), are present in the ET-1 proximal promoter
region, of which, HIF-1α is a key transcription factor in
the hypoxia-induced ET-1 gene expression [27,28].
Based on the theory that epigenetics plays an important
role in the developmental origins of adult disease, we
hypothesized that IUGR induced by nutrient restriction
could cause epigenetic modification of the PAH-related
genes (ET-1), that persists into later life. These epigenetic
changes would induce individuals to be highly sensitive to
hypoxia or other stimuli, resulting in PAH or pulmonary
vascular remodeling. To better understand the role of
epigenetics, we performed this study at a cellular level
by magnetic-activated cell sorting (MACS).
Methods
Intrauterine growth retardation (IUGR) rat model
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.
All procedures and protocols were approved by the
Committee on the Ethics of Animal Experiments of
Zhejiang University. All surgery was performed under
anesthesia, and all efforts were made to minimize suffer-
ing. The IUGR rat model was established based on our
previous study [29]. Virgin female Sprague–Dawley rats
weighing 250-300 g obtained from Zhejiang UniversityLaboratory Animal Center were mated overnight. After
confirmation of mating, the pregnant rats were ran-
domly divided into two nutritional groups: standard diet
ad libitum throughout gestation (Control group), and
undernutrition group. Pregnant rats in the control
group were fed a standard commercial rat diet, while
pregnant rats in the undernutrition group were fed the
same diet at 50% of the free intake until birth. Both
groups of rats were kept in the same room with a
constant temperature maintained at 22 ± 3°C, and free
to drink. Food intake and maternal weights were
recorded daily until delivery. The establishment of
IUGR newborn rats is based on the normal birth weight.
Those pups whose birth weight was below the 10th
percentile of normal birth weight were defined as IUGR
rats, and the litter size was culled to five pups per litter
to assure adequate nutrition until weaning. The newborn
pups from control group were considered as normal birth
weight group “Control d1” and those newborn pups from
the undernutrition group were labeled as IUGR group
“IUGR d1”. Newborn IUGR rats continued to be reared
by diet-restricted mothers that receive normal food intake
through lactation, the control pups were reared by control
mothers. Both group rats were raised until 6 weeks of age.
Six-week control rats were labeled as “Control 6wks”,
while 6-week IUGR rats were labeled an “IUGR 6wks”
(Figure 1).Hypoxic pulmonary hypertension rat model
Hypoxic pulmonary hypertension model was established
according to our previous experiments [30,31]. Briefly, 4-
week IUGR rats and the age-matched control rats were
placed in a normobaric hypoxic chamber with a fraction of
inspiratory oxygen concentration of 12% for two weeks.
During the experiment, the chamber was opened for 10
minutes every day for feeding and to change the animal
cages. After a 2-week hypoxic intervention, rat pulmonary
arterial pressure was measured, followed by lung tissue
immunohistochemistry and isolation of pulmonary vascular
endothelial cells. The control and IUGR rats with hypoxia
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hypoxia”, respectively.
Assessment of pulmonary arterial pressure
The right ventricular systolic pressure (RVSP) was used
to reflect pulmonary arterial pressure. Measurement of
RVSP of 6-week rats was performed according to our
previous report [31]. Briefly, 6-week rats were anesthe-
tized (Urethane, 50 mg/kg, intraperitoneal injection),
followed by tracheal intubation and immediately con-
nected to a ventilator with 12% O2 for the hypoxic
group, and then the thorax was opened. A catheter con-
nected to a pressure transducer was inserted into the
right ventricle, and RVSP was recorded immediately.
Normal saline was injected into the right ventricle
through the needle at a pressure of 20 cmH2O at room
temperature and the lung was flushed. Lungs were dis-
sected once the effluent from the left atrium incision
was clear of blood.
Immunohistochemistry and physical measurements
Right lung tissues of different ages were removed, frozen
in liquid nitrogen and stored at −80°C for Western
blotting. Left lung tissues of different ages were isolated
and perfused with ice cold 10% formalin at a pressure of
25 cm H2O and fixed for 24 hours at 4°C. The lung tissues
were imbedded in paraffin, sectioned at 4–5 μm, and
processed for light microscopic immunohistochemistry as
the previously described [19,30]. Samples were incubated
with a primary antibody against smooth muscle specific
α-actin (α-SMA, clone: 1A4, Dako) overnight, followed by
secondary goat antibody (HRP polymer) for 30 minutes at
37°C. At least eight slides from each lung were taken and
then analyzed.
The percentage of pulmonary arterial medial thick-
ness occupied by smooth muscle was determined
according to our previous study [30]. Small pulmonary
arteries of 50-150 μm in diameter were investigated via
a systematic sampling method to evaluate random, non-
overlapping calibrated fields for each variable. The terminal
bronchioles were used as the independent landmark for
selecting small pulmonary arteries [32]. We used Image Pro
Plus software (Media Cybernetics) to make the measure-
ments. Tissue slides were analyzed by technician who was
without knowledge of the group from which the tissue was
taken.
Isolation of pulmonary vascular endothelial cells (PVEC)
Pulmonary vascular endothelial cells (PVEC) were isolated
by magnetic-activated cell sorting (MACS) as described
earlier [19]. Fresh rat lungs were sliced and then incubated
with collagenase A. The suspensions were filtered, centri-
fuged, and washed three times in phosphate buffer saline
(PBS) containing 0.5% bovine serum albumin (BSA) and2 mM EDTA. The final pellets were resuspended in 100 μl
of PBS with 0.5% BSA and 2 mM EDTA per 107 total
cells, and then incubated with PECAM-1 (555027, BD)
for 15 minutes at 4°C. After washing, anti-PE MicroBeads
(130-048-801, Miltenyi Biotec) were added to the cell
suspension for 15 minutes at 4°C. The PVEC positively
labeled with the magnetic microbeads linked to PECAM-1
antibody were selected with the separation unit, and kept
at −80°C until use. The proportion of positive PVEC after
MACS was about 92% [19], there were no significantly
statistical difference between groups.
Western blot detection for α-SMA and endothelin-1
proteins
Total protein extracts and protein concentrations were
prepared according to our previous studies [19,30]. Thirty
micrograms of protein extracts were resolved on 8-10%
SDS polyacrylamide gels for α-SMA (42kDa) and ET-1
(21kDa) proteins. Proteins were transferred onto a polyvi-
nylidene fluoride (PVDF) membrane using a BioRad gel
blotting apparatus. Membranes were incubated with a
primary antibody against α-SMA and ET-1 overnight at
4°C and with a peroxidase-conjugated secondary antibody
for 60 minutes at room temperature. Peroxidase was
visualized by enhanced chemiluminescence (ECL) and
exposure to ECL films for appropriate times. The bands of
Western blots were quantitated by densitometry and
normalized with β-actin (42kDa) using Image Pro Plus
software. Protein level is expressed as a percentage of
normal control ± standard error of the mean (SEM).
Quantitative real-time PCR for ET-1
Total RNA was isolated from PVECs according to the
RNeasy protocol (Axygen). RNA was reverse-transcribed
using a reverse transcriptase kit (TAKARA) according to
manufacturer’s protocols. Real-time quantitative PCR
was performed by the ABI Prism 7500 Instrument
following the TAKARA protocol. β-actin was used as an
internal control. Primers for ET-1 and β-actin are as




Chromatin immunoprecipitation (ChIP) assay was per-
formed as described in a previous study [19]. After the iso-
lated PVEC were fixed and cross-linked, the cell pellets
were suspended in cell lysis buffer and centrifuged, and
the supernatants were discarded. The pellets were resus-
pended in SDS lysis buffer, sonicated, centrifuged and
aliquots of soluble chromatin were collected. Aliquots of
the supernatants were retained for representing the input
chromatin. Aliquots were incubated overnight at 4°C with
one of the following antibodies: 5 μl anti-acetylaled
Figure 2 Comparison of right ventricular systolic pressure
(RVSP) of different groups. *P < 0.05 as compared with Control
6wks (weeks), and IUGR 6wks, respectively; **P < 0.05 as compared
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Histone H3 (Lys9/18) (H3K9/18, 07–593, Millipore), 5 μl
anti-acetylaled Histone H4 (06–866, Millipore), anti-
Hypoxia Inducible Factor 1 α (MAB5382, Millipore). The
immune complexes were precipitated with Protein A beads
and then eluted. The input, unbound and bound fractions
were incubated with 5 M NaCl to reverse crosslink. The
DNA fragments were purified using the Qiaquick PCR
Purification kit (QIAGEN). The DNA fragments containing
ET-1 site-specific sequences were quantified by real-time
PCR. Relative quantification of PCR products were based
on value differences between the bound and input using
the △△Ct method. The PCR primers for the ET1 gene
promoter were as follows: ET1 promoter A1, F5’-
ttgcctgtgggtgactaatc-3’, R5’-ccttcaccggagcgaaag-3’ (−197
to +25); ET1 promoter A2, F5’-cctcttgattcttgaactctggg-3’,
R5’-attagtcacccacaggcaac-3’ (−397 to −179).with Control 6wks, IUGR 6wks, and Control hypoxia, respectively.
(n ≥ 8).Statistic analysis
Values are expressed as mean ± SEM (standard error of
mean). The continuous variables in the different groups
were compared by one-way ANOVA. Multiple compari-
sons were performed utilizing the Student-Newman-Keuls
test. A difference of P < 0.05 was considered to be statisti-
cally significant.Results
Establishment of rat IUGR model
In the present study, the 10th and 90th percentiles for
normal newborn rat birth weight were 5.87 g and 7.60 g,
respectively. Newborn rats weighing less than 5.80 g
were considered to be IUGR. The average birth weight
of normal newborn rats (n = 276) was 6.80 g ± 0.044 g,
while the average birth weight of newborn rats from the
diet restricted group (n = 305) was 5.10 g ± 0.037 g.
There was statistically significant difference between the
two groups (P < 0.001). The sampling age of different
experimental group rats were seen in Figure 1.Right ventricular systolic pressure (RVSP) of 6-week,
hypoxia-treated rats
RVSP of 6-week control rats was 21.6 ± 2.08 mmHg,
and the RVSP of 6-week IUGR rats was 22.93 ± 1.60
mmHg, there was no significant statistical difference
between the two groups (P = 0.622, Figure 2). After
hypoxia intervention, the RVSP of both groups
increased significantly. The RVSP of the IUGR hyp-
oxia group was statistically significantly higher than
that of the Control hypoxia group (P = 0.04), which
indicates that IUGR rats were more sensitive to hyp-
oxia than normal control rats.Pulmonary histological changes in 1-day, 6-week,
hypoxia-treated rats
The percentage of medial thickness in small pulmonary
arteries of 50–150 μm diameter was analyzed. The med-
ial/(medial + lumen) thickness ratios of IUGR d1 group
rats were lower than those of Control d1 group rats, but
there was no statistically significant difference between
the two groups (0.2678 ± 0.012 versus 0.2384 ± 0.013, P =
0.152). Although the medial thickness ratios of IUGR
6wks group rats were slightly higher than those of age-
matched control rats, there was no statistically signifi-
cant difference between the two groups (0.3397 ±
0.011 versus 0.3393 ± 0.015, P = 0.986).
Significant histological changes compatible with pul-
monary vascular remodeling were observed in hypoxia-
treated rats, especially in IUGR rats. The medial thickness
ratios of hypoxia-treated rats were significantly higher
than those of age-matched control and IUGR rats. More-
over, the medial thickness ratios of IUGR hypoxia group
rats were higher than those of Control hypoxia group
(0.4295 ± 0.019 versus 0.3743 ± 0.014). There was a
statistically significant difference between the two
groups (P = 0.019) (Figure 3).
Lung tissue α-SMA levels
Lung tissue α-SMA protein expression levels reflecting
pulmonary vascular remodeling in IUGR hypoxia and
Control hypoxia groups were significantly increased
(Figure 4A). Furthermore, the α-SMA level of the IUGR
hypoxia group was higher than that of Control hypoxia
group, which yielded a significant difference (P < 0.01).
This further indicated that the sensitivity to hypoxia in
IUGR rats was significantly higher than the normal
control group.
Figure 3 Immunohistochemical staining for a-SMA in lung tissue sections. Representative lung histological sections of Control d1 (A), IUGR
d1 (B), Control 6wks (C), IUGR 6wks (D), Control hypoxia (E), and IUGR hypoxia (F) are shown demonstrating hypertrophy of the arterial medial
wall induced by hypoxia. Note significant medial thickness (E and F), especially in IUGR hypoxia group (x 200). The bar graph represents the
medial/(medial + lumen) thickness ratios of the small pulmonary arteries in various group rats, *P < 0.05 as compared with control d1, and IUGR
d1, respectively; **P < 0.05 as compared with control d1, IUGR d1, Control 6wks, IUGR 6wks, and Control hypoxia, respectively. PA = pulmonary
artery. (n = 10).
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Although the ET-1 protein level of the IUGR d1 group
was higher than the age-matched control group, there
was no significantly statistical significance (P > 0.05,
Figure 4B). The ET-1 protein level of the IUGR 6wks
group was similar to that of the Control 6wks group,
there was no significant difference (P > 0.05). However,
the ET-1 expression level in the IUGR hypoxia group
was significantly higher than that in Control hypoxia
group, and there was a statistically significant difference
between the two groups (P = 0.02). Similar to protein
expression pattern, the ET-1 mRNA expression showed
a similar trend (Figure 4C). These results indicate that
the increased ET-1 level of IUGR hypoxia group ratsmight be responsible for the increased RVSP and
pulmonary vascular remodeling changes.
The ET-1 gene promoter histone code of PVEC
Two sites along the ET-1 promoter were analyzed for
acetylated histone H3 and H4. Acetylation levels of every
specific site in IUGR rats were quantified by ChIP/real-
time PCR and expressed as an increased fold relative to
the age-matched controls. The levels of acetylated histone
H3 in the ET-1 promoter A1 region of PVEC from IUGR
d1, IUGR 6wks, and IUGR hypoxia groups were signifi-
cantly higher than those from the age-matched control
groups (P < 0.01, Figure 5A). While in the ET-1 promoter
A2 region, only the IUGR hypoxia group was higher than
Figure 4 Expression of α-SMA and ET-1 proteins was measured using Western blot analysis. Lung tissue protein extractions were used for
α-SMA expression analysis (A). The bar graph represents the α-SMA protein relative levels (percent of Control d1 ± SEM). *P < 0.05 as compared
with Control d1, IUGR d1, Control 6wks, and IUGR 6wks groups, respectively; **P < 0.05 as compared with Control d1, IUGR d1, Control 6wks,
IUGR 6wks, and Control hypoxia groups, respectively (A); note increased α-SMA expression in the IUGR hypoxia group. PVEC protein extractions
were used for ET-1 expression analysis (B). The bar graph represents the ET-1 protein relative levels (percent of control d1 ± SEM); *P < 0.05 as
compared with Control d1 and IUGR d1; **P < 0.05 as compared with Control d1, IUGR d1, Control 6wks, IUGR 6wks, and Control hypoxia groups,
respectively (B); note increased ET-1 expression in the IUGR hypoxia group. β-actin protein expression serves as an internal control and is used to
normalize the protein band intensity (n = 4). The relative ET-1 mRNA levels were examined by quantitative real-time PCR (C), *P < 0.05 as
compared with control d1, and IUGR d1, respectively; #P < 0.05 as compared with control d1, IUGR d1, Control 6wks, IUGR 6wks, and IUGR
hypoxia, respectively; **P < 0.05 as compared with control d1, IUGR d1, Control 6wks, IUGR 6wks, and Control hypoxia, respectively (n = 4).
Con = Control, SEM = standard error of mean.
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lated H3K9/18 levels in the ET-1 promoter of PVEC was
similar to the acetylated histone H3 change (Figure 5B).
The levels of acetylated histone H4 in the ET-1 promoter
regions from IUGR d1 and 6wks groups were similar to the
age-matched control groups (Figure 6A). However, the level
of acetylated histone H4 in the ET-1 promoter A1 and A2
regions of the IUGR hypoxia group was significantly
higher than that of Control hypoxia group, there were sta-
tistically significant differences (P = 0.011 and P = 0.021,
respectively).Hypoxia inducible factor-1α (HIF-1α) enrichment in ET-1
gene promoter of PVEC
To explore the role of transcription factor HIF-1α in
hypoxia-induced pulmonary hypertension, HIF-1α binding
levels of the ET-1 gene promoter in PVEC between the
IUGR and control groups were analyzed. The HIF-1α
binding levels in the ET-1 gene promoter A1 region from
the IUGR d1, 6wks and hypoxia groups were higher than
the age-matched control groups, and there were sta-
tistically significantly statistical differences (P < 0.05,
Figure 6B). There were also similar changes in HIF-1α
Figure 5 Comparison of histone H3 (A) and H3K9/18 (B)
acetylation levels at the rat ET-1 promoter between IUGR and
the control using ChIP and relative quantitative real-time PCR.
A1 and A2 represent two areas of the ET-1 gene promoter (−197
to +25 and −397 to −179), respectively. Data are expressed as IUGR
percent of the Control ± SEM. *P < 0.05 and **P < 0.01 as compared
with Control groups, respectively.
Figure 6 Comparison of histone H4 acetylation (A) and HIF-
1.alpha; binding (B) levels at the rat ET-1 promoter between
IUGR and the control using ChIP and relative quantitative real-
time PCR. A1 and A2 represent two areas of the ET-1 gene
promoter (−197 to +25 and −397 to −179), respectively. Data are
expressed as IUGR percent of the Control ± SEM. *P < 0.05 and
**P < 0.01 as compared with Control groups, respectively.
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except between the IUGR d1 and Control d1 groups.
The ChIP experiments revealed that histone acetylation
modification of the ET-1 gene promoter in IUGR rats
might induce transcription factor HIF-1α accumulation in
the ET-1 promoter region, which would lead to the ET-1
gene transcription and protein expression.
Discussion
The ‘histone code’ hypothesis proposes that covalent mod-
ifications of the histone proteins contribute to transcrip-
tional regulation. These histone modifications provide a
mechanism that allows encoding information of successive
generations of cell division [33,34]. Generally, increased
levels of histone acetylation are associated with increased
transcriptional activity, whereas decreased levels of acetyl-
ation are correlated with suppressed gene expression. Our
data demonstrate that the open chromatin domains
marked by histone H3 and H3K9/18 acetylation at theproximal promoter of ET-1 in IUGR rats are essential for
transcription. Upregulated ET-1 protein expression in
PVEC from IUGR hypoxia rats is closely associated with
the presence of increased acetylated H3 histones. Reduc-
tion of these markers in Control hypoxia rats results in
the decreased ET-1 protein expression.
In the present study, PVEC isolated from IUGR day1
rats shows a significant increase in H3 and H3K9/18
acetylation at the proximal promoter of ET-1, and can
be continued until 6 weeks after birth. These epigenetic
markers would contribute to the higher sensitivity in
IUGR rats in later life to hypoxia, leading to more
pronounced PAH or pulmonary vascular remodeling
than the normal rats. The increased histone acetylation
of the ET-1 gene in the IUGR hypoxia rats up-regulated
ET-1 protein expression, inducing a more significant
PAH. In general, histone acetylation will lead to increase
in gene expression. However, under normal oxygen
conditions, although ET-1 protein expression in IUGR
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group, there was no significant difference between the
two groups. Moreover, ET-1 protein level in 6-week
IUGR rats was similar to the age-matched control
group. The ET-1 protein expression mode in part
explained the fact that 6-week IUGR rats, under
normoxia, did not produce more significant pulmonary
arterial pressure and pulmonary vascular remodeling
than the age-matched control rats. Our data demon-
strates that the histone acetylation of the ET-1 gene in
6-week IUGR rats is not enough to cause ET-1 protein
expression. In addition to histone acetylation, other
epigenetic alterations including RNA interference might
also be involved in regulation of the ET-1 gene to sup-
press expression of ET-1 protein. While these possible
epigenetic modifications would be likely to induce ET-1
protein expression only in specific stress situations.
However, this balance was broken by hypoxia interven-
tion. The ET-1 protein level of PVEC from the IUGR
hypoxia group was significantly higher than Control
hypoxia group. The up-regulated ET-1 protein level was
consistent with increased RVSP and pulmonary vascular
remodeling observed in IUGR hypoxia rats. The molecularFigure 7 Development of hypoxic pulmonary arterial hypertension fo
acetylation and transcription factor HIF-1α binding levels in the ET-1 gene
These epigenetic changes would induce IUGR individual in later life to be h
hypertension (B). AC = (Histone) acetylation, SMC = smooth muscle cells, Pmechanism responsible for the increased ET-1 protein
expression in IUGR hypoxia rats is likely to be strongly
related to the recruitment of hypoxia-induced transcrip-
tional factors in the activated (increased histone acetylation)
ET-1 promoter, especially the recruitment of HIF-1α.
HIF-1 is a heterodimer consisting of HIF-1α and HIF-1β
subunits, which functions as a key regulator responsible for
hypoxia-inducible gene expression [35,36]. In normoxia,
the HIF-1α proteins are rapidly degraded. While during
hypoxia, HIF-1α becomes stabilized and translocates to
the nucleus, where it forms the activated HIF complex
and co-induces target gene expression. Our study
revealed that the recruitment of HIF-1α in the ET-1
promoter in PVEC of IUGR newborn rats was signifi-
cantly increased, and continued until 6 weeks after
birth. Furthermore, this trend persisted even after
hypoxia intervention. The increased HIF-1α binding
level in the ET-1 promoter of IUGR rats would contrib-
ute to ET-1 protein expression, which further exacer-
bates pulmonary arterial pressure and pulmonary
vascular remodeling in IUGR rats (Figure 7).
A previous report demonstrated that in mice undernutri-
tion during gestation would induce pulmonary vascularllowing IUGR. Maternal nutrient restriction increased the histone
promoter of pulmonary vascular endothelial cells (PVEC) in IUGR rats.
ighly sensitive to hypoxia, resulting in more significant pulmonary
AH = pulmonary arterial hypertension.
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tissue [18]. Different from their study at a tissue level, we
focused on a cellular level to investigate the role of epigen-
etics of the special gene in development of hypoxic PAH
following IUGR. Whether RNA interference, DNA methy-
lation, or other hypoxia-induced transcription factors were
involved in development of hypoxic PAH following IUGR,
whether these epigenetic changes were maintained into
next generation or could be reversed, would deserve further
investigation.
Conclusions
In summary, we found that hypoxia induced IUGR rats
experience significant PAH and pulmonary vascular
remodeling. The response characteristics of IUGR to
hypoxia were strongly correlated with the increased his-
tone acetylation and HIF-1α binding levels in the ET-1
gene core promoter region. These findings suggest that
epigenetics are closely associated with the development
of hypoxic PAH following IUGR, further providing a
new insight for improved prevention of IUGR-related
PAH.
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